Physician profile
Grace C Yu
NPI 1548797863
$502.92
in general payments reported to CMS, 2019-2025
14 companies · $150 in 2025
The $150 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.13 · 2023: $107 · 2024: $227 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $485.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $484.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $107.67 | 2023-2025 | Azstarys |
| Cranial Technologies, INC | $69.11 | 2024-2025 | Doc Band |
| Tris Pharma INC | $55.68 | 2023-2025 | Dyanavel Xr |
| Pfizer INC. | $45.43 | 2024-2025 | |
| Ironshore Pharmaceuticals INC. | $44.62 | 2024 | |
| Merck Sharp & Dohme LLC | $41.66 | 2024-2025 | Gardasil 9, Vaxelis, Gardasil |
| Alk-Abello, INC | $22.22 | 2023 | Odactra, Ragwitek, Grastek |
| Collegium Pharmaceutical, INC. | $20.30 | 2025 | Jornay Pm |
| Verrica Pharmaceuticals INC. | $18.43 | 2024 | Ycanth |
| Dexcom, INC. | $18.19 | 2023 | Dexcom G6 Transmitter |
| Astellas Pharma US INC | $18.13 | 2019 | |
| Idorsia Pharmaceuticals US INC | $15.28 | 2023 | Quviviq |
| Novo Nordisk INC | $13.11 | 2024 | |
| Tms Neurohealth Centers INC. | $13.09 | 2025 | Tms Neurohealth Centers INC. |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grace Yu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.